L-R: Dr Benjamin Seet, Executive Director of the Biomedical Research Council, A*STAR; His Excellency Bruce Gosper, the Australian High Commissioner to Singapore; Dr Steven Fang, Chief Executive Officer / Founder, Invitrocue Ltd; The Hon Martin Hamilton Smith, Minister for Trade and Investment, South Australian Government; Dr Raj Thampuran, Managing Director, A*STAR; Professor Ng Huck Hui, …
July 03, 2017 – Invitrocue Limited (ASX:IVQ), a leading healthcare bio-analytic solutions providers, is pleased to announce that it has been granted Human Research Ethics Committee approval to understand a cancer research study with Sydney’s Garvan Institute of Medical Research, to provide further clinical validation of Invitrocue technology for use in personalised real-time screening of …
22 May, 2017 – Invitrocue (ASX:IVQ) announced today that it will be expanding its cell-based assaying business into skin and wound healing. Invitrocue will develop robust and easy-to-use in vitro assays to assess the safety and effectiveness of consumer antiseptics and over-the-counter (OTC) wound dressing products. Invitrocue has signed a Master Services Agreement with Mundipharma …
Invitrocue is featured in the first episode of A*STAR TV Business Insider. Watch this broadcast as it tells the story of company, the technology and the people. By loading the video, you agree to YouTube’s privacy policy.Learn more Load video Always unblock YouTube
Event: Asia Malaria Images Exhibition Opening Talk (Singapore) Venue: The Pod, Level 16, National Library Board, 100 Victoria Street, Singapore 18806 Date: 09 September 2017, Saturday Invitrocue is proud to be an official sponsor of the Asia Malaria Image campaign as part of the Company’s corporate social responsibility initiative. Mark this day and visit …
Singapore-Australia cooperation on science and technology takes off ; Landing Pad start-up accelerator is latest initiative in strategic partnership The Singapore Government has also boosted co-investment support for promising start-ups specialising in deep-technology, such as medical technology, clean technology and advanced manufacturing and engineering. “Collectively, we expect these initiatives to further boost the local …
SPEECH BY MR S ISWARAN, MINISTER FOR TRADE AND INDUSTRY (INDUSTRY), AT THE OFFICIAL OPENING OF THE AUSTRALIAN LANDING PAD IN SINGAPORE, ON MONDAY, 13 MARCH 2017, 1040 HRS, AT BASH (79 AYER RAJAH CRESCENT) International connections are critical to facilitating innovation and supporting Singapore’s startup ecosystem. Excerpt:- 8. One example is home-grown local startup …
SPEECH BY MR LIM HNG KIANG, MINISTER FOR TRADE AND INDUSTRY (TRADE), DURING THE COMMITTEE OF SUPPLY DEBATE UNDER HEAD V (MINISTRY OF TRADE AND INDUSTRY) ON FRIDAY, 3 MARCH 2017 STAYING OPEN AND CONNECTED Excerpt:- 32. In addition, Singapore companies can partner larger companies to venture abroad. Invitrocue, a home grown biotechnology firm that was spun-off from A*STAR, …
February 23, 2017 – Invitrocue (ASX: IVQ) is pleased to announce that the company has signed a Collaborative Research Master Agreement with the Garvan Institute of Medical Research. The aim of the collaboration is to provide further medical validation of Invitrocue’s technology for use in personalised real time screening of cancer drugs. It is envisaged …
Invitrocue (ASX:IVQ) will be holding our inaugural AGM on the 30th of November. Click here for AGM Notice.